Novo Nordisk plans major price cuts for several insulins
Published
Novo Nordisk will start slashing some U.S. insulin prices up to 75 percent next year, following a path set earlier this month by rival Eli Lilly. The Danish drugmaker said Tuesday that pre-filled pens and vials of long- and short-acting insulins will see list price reductions. They include…
#novonordisk #elililly #danish #levemirnovolin #novolog #novo #insulinaspart #flexpen #flexpens #elilillyandco